Zobrazeno 1 - 10
of 585
pro vyhledávání: '"J. Puolakka"'
Publikováno v:
Journal of Orthopaedic Surgery & Research. 10/12/2024, Vol. 19 Issue 1, p1-11. 11p.
Autor:
Siar, El Hocine1,2 (AUTHOR) hocines1@hotmail.fr, Abellanas-Perez, Pedro1 (AUTHOR) m.a.p@icp.csic.es, Rocha-Martin, Javier3 (AUTHOR) javrocha@ucm.es, Fernandez-Lafuente, Roberto1 (AUTHOR) javrocha@ucm.es
Publikováno v:
Molecules. Aug2024, Vol. 29 Issue 15, p3674. 13p.
Autor:
A.O.I. Krause, K. J. Puolakka
Publikováno v:
Catalysis Letters. 116:87-93
CO2 reforming and the combined CO2 reforming and partial oxidation reaction of selected fuel compounds were studied on a commercial 15 wt% NiO/Al2O3 catalyst and a 0.25 wt% Rh/ZrO2 catalyst at 600–900 °C. Oxygen reduced the energy requirement and
Publikováno v:
Diabetes, Obesity and Metabolism. 2:293-298
SUMMARY Aim Type 2 diabetes and metabolic syndrome are major cardiovascular risk factors in postmenopausal women, but the role of vasoconstrictive endothelin-1 (ET-1) in these conditions is not known. We studied the levels of ET-1 and the effect of p
p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer
Autor:
Kari Syrjänen, Veli-Matti Kosma, Maarit Anttila, Hongxiu J, Matti Juhola, Seppo Saarikoski, J. Puolakka
Publikováno v:
British Journal of Cancer
The role and prognostic value of the tumour suppressor p21/WAF1 expression in epithelial ovarian cancer has not yet been defined. Therefore, the expression of p21/WAF1 was assessed immunohistochemically (IHC) in 316 epithelial ovarian malignancies in
Autor:
P. Lahteenmaki, M. Haukkamaa, J. Puolakka, U. Riikonen, S. Sainio, J. Suvisaari, C. G. Nilsson, A. Prentice
Publikováno v:
BMJ. 316:1122-1126
Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy {#article-title-2} Objectives: To assess whether the levonorgestrel intrauterine system could provide a conservative alternative to hysterecto
Autor:
J. Heikkinen, Anja Virkkunen, Fredrika Pekonen, Anna-Maija Rautio, Helena Sundström, Torsten Wahlström, Salmi T, Elina Granfors, Sakari Telimaa, Erkki Hirvonen, G. Wilen-Rosenqvist, J. Puolakka, Leo Mäkäräinen, Seppo Hulkko, Simo Nummi
Publikováno v:
Maturitas. 21:39-44
We evaluated whether a progestin, added for 14 days every 3 months to estrogen replacement therapy, is capable of preventing the development of endometrial hyperplasia in postmenopausal women during a treatment period of 2 years. Postmenopausal women
Publikováno v:
Acta orthopaedica Scandinavica. 72(1)
Wear of the socket liner and resulting osteolysis are the major causes of failure in cementless hip arthroplasties. We report alarming wear of the first-generation polyethylene liner of the cementless porous-coated Biomet Universal cup. Radiographs o
Autor:
Marja-Riitta Taskinen, Marju Tilly-Kiesi, J. Puolakka, Mikko Lappi, Juhani Kahri, T. Pyörälä, S. Lahdenperä, H. Luotola
Publikováno v:
Atherosclerosis. 129(2)
Seventy postmenopausal women took part in the study. Subjects received either continuous oral 17 beta-estradiol 2 mg/day combined with norethisterone acetate 1 mg/day (E2/NETA, Kliogest) or transdermal treatment consisting of 28 day cycles with patch
Autor:
J. Puolakka, Kari Nieminen
Publikováno v:
Acta obstetricia et gynecologica Scandinavica. 76(1)
To study whether paracervical block (PCB) with 12.5 mg (0.125%) of bupivacaine is as effective as with 25 mg (0.25%) and if there are differences in fetal heart rate (FHR) patterns between the doses.A prospective, randomized double-blind study. Fifty